As of September 30, 2024, the Company had cash, cash equivalents, and marketable securities of $138.0 million. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on IKNA: Ikena Oncology’s Gamble: Slashing Workforce by Half Could Derail Strategic Plans
